☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
RedHill
PharmaShots Weekly Snapshots (Feb 15- 19, 2021)
February 19, 2021
RedHill Signs a Manufacturing Agreement with Cosmo for Movantik and RHB-204
February 19, 2021
PharmaShots Weekly Snapshot (January 4-8, 2020)
January 8, 2021
RedHill Replaces its Co-Commercialization Agreement with Daiichi Sankyo for Movantik (naloxegol)
August 4, 2020
PharmaShots Weekly Snapshot (Jun 15-19, 2020)
June 22, 2020
PharmaShots Weekly Snapshot (Dec 30, 2019-Jan 03, 2020)
January 6, 2020
RedHill Biopharma Reports Results of Opaganib in P-II/III Study for the Treatment of Severe COVID-19
February 8, 2022
PharmaShots Weekly Snapshots (January 10 - 14, 2022)
January 14, 2022
RedHill Biopharma Reported New Data From a Prespecified Analysis of All Oral Opaganib's P-II/III Study in Severely Ill Hospitalize...
January 14, 2022
PharmaShots Weekly Snapshots (Feb 15- 19, 2021)
February 19, 2021
RedHill Signs a Manufacturing Agreement with Cosmo for Movantik and RHB-204
February 19, 2021
PharmaShots Weekly Snapshot (January 4-8, 2020)
January 8, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.